Author

A. Lackenby

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1 Organism:virus· 1

Frequent Co-Authors

D. Goldhill· 2 shared M. Galiano· 2 shared M. Zambon· 2 shared S. Miah· 2 shared W. S. Barclay· 2 shared A. Gallego-Cortes· 1 shared A. Yan· 1 shared H. Xie· 1 shared

Activity by Year

2018-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 41 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

D. Goldhill

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Favipiravir-resistant influenza A virus shows potential for transmission

D. Goldhill, A. Yan, R. Frise, J. Zhou, J. Shelley, A. Gallego-Cortes, S. Miah, O. Akinbami, M. Galiano, M. Zambon, A. Lackenby, W. S. Barclay

This study shows favipiravir-resistant influenza A virus can transmit in ferrets but may lose its resistance mutation in vivo due to fitness trade-offs.

bioRxiv · Sep 1, 2020Microbiology

Determining the Mutation Bias of Favipiravir in Influenza Using Next-generation Sequencing

D. Goldhill, P. Langat, H. Xie, M. Galiano, S. Miah, P. Kellam, M. Zambon, A. Lackenby, W. S. Barclay

This study uses next-generation sequencing to determine the mutation bias caused by favipiravir in influenza virus RNA, showing it primarily acts as a guanine analogue and secondarily as an adenine analogue.

bioRxiv · Jul 23, 2018Microbiology